These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
715 related articles for article (PubMed ID: 18269340)
1. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease. Mitsuyama K; Sata M Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340 [TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of probiotics in inflammatory bowel diseases. Mach T J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485 [TBL] [Abstract][Full Text] [Related]
4. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C; Whelan K; Lindsay JO Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082 [TBL] [Abstract][Full Text] [Related]
5. Microecology as a target for therapeutic intervention in inflammatory bowel disease. Guarner F IDrugs; 2003 Sep; 6(9):868-73. PubMed ID: 12964066 [TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease, gut bacteria and probiotic therapy. Reiff C; Kelly D Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289 [TBL] [Abstract][Full Text] [Related]
8. Novel drug delivery strategies for the treatment of inflammatory bowel disease. Kesisoglou F; Zimmermann EM Expert Opin Drug Deliv; 2005 May; 2(3):451-63. PubMed ID: 16296767 [TBL] [Abstract][Full Text] [Related]
9. Gut microbiota and inflammatory bowel disease. Hammer HF Dig Dis; 2011; 29(6):550-3. PubMed ID: 22179210 [TBL] [Abstract][Full Text] [Related]
10. Clinical utility of probiotics in inflammatory bowel disease. Cain AM; Karpa KD Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Geier MS; Butler RN; Howarth GS Int J Food Microbiol; 2007 Apr; 115(1):1-11. PubMed ID: 17137666 [TBL] [Abstract][Full Text] [Related]
12. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how. Prantera C; Scribano ML Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096 [TBL] [Abstract][Full Text] [Related]
13. Evolving knowledge and therapy of inflammatory bowel disease. Korzenik JR; Podolsky DK Nat Rev Drug Discov; 2006 Mar; 5(3):197-209. PubMed ID: 16518373 [TBL] [Abstract][Full Text] [Related]
14. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease. Karimi O; Peña AS J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S136-41. PubMed ID: 18806706 [TBL] [Abstract][Full Text] [Related]
15. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? Seksik P; Dray X; Sokol H; Marteau P Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087 [TBL] [Abstract][Full Text] [Related]
16. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management]. Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439 [TBL] [Abstract][Full Text] [Related]
17. Prebiotics as gut microflora management tools. Gibson GR J Clin Gastroenterol; 2008 Jul; 42 Suppl 2():S75-9. PubMed ID: 18542038 [TBL] [Abstract][Full Text] [Related]
18. Probiotics for inflammatory bowel disease: a critical appraisal. Sans M Dig Dis; 2009; 27 Suppl 1():111-4. PubMed ID: 20203506 [TBL] [Abstract][Full Text] [Related]